High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal
- 15 June 2007
- journal article
- Published by Wiley in Movement Disorders
- Vol. 22 (8) , 1194-1201
- https://doi.org/10.1002/mds.21525
Abstract
Mutations in the Leucine‐Rich Repeat Kinase 2 (LRRK2) gene are the most frequent known cause of Parkinson's disease (PD), but their prevalence varies markedly between populations. Here we studied the frequency and associated phenotype of four recurrent LRRK2 mutations (R1441C, R1441G, R1441H, and G2019S) in familial and sporadic PD from a single referral center in Lisbon, Portugal. Among 138 unrelated PD probands, we identified 9 heterozygous G2019S carriers (6.52%) and 1 heterozygous R1441H carrier (0.72%). The G2019S mutation was present in 4 of the 107 sporadic (3.74%) and in 5 of the 31 familial probands (16.1%). Mutations were not found among 101 Portuguese controls. The G2019S mutation was present on a single haplotype and displayed reduced penetrance. Heterozygous parkin gene mutations were also found in 2 G2019S‐positive probands, but their pathogenic role is unclear. The clinical phenotype in patients with LRRK2 mutations was indistinguishable from that of typical PD, including impaired sense of smell. The G2019S mutation is a very common genetic determinant among the Portuguese patients with PD, and the R1441H mutation is also present in this population. These data have important implications for the diagnostic work‐up and genetic counseling of patients with this disease in Portugal. © 2007 Movement Disorder SocietyKeywords
This publication has 42 references indexed in Scilit:
- Digenic parkinsonism: Investigation of the synergistic effects of PRKN and LRRK2Neuroscience Letters, 2006
- LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia AgoAmerican Journal of Human Genetics, 2006
- Validity and Utility of a LRRK2 G2019S Mutation Test for the Diagnosis of Parkinson's DiseaseGenetic Testing, 2006
- Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countriesMovement Disorders, 2006
- Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*Brain, 2005
- Lrrk2 pathogenic substitutions in Parkinson's diseaseneurogenetics, 2005
- Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's diseaseNeuroscience Letters, 2005
- Genetic screening for a single common LRRK2 mutation in familial Parkinson's diseaseThe Lancet, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- How much phenotypic variation can be attributed to parkin genotype?Annals of Neurology, 2003